Benznidazole IND for Chagas Disease Receives Clearance by FDA Jun 27, 2017 08:00AM
KaloBios Receives M&A Advisor 2017 Turnaround Award Mar 27, 2017 08:00AM
KaloBios Now Current on SEC Periodic Filings Sep 23, 2016 04:45PM
KaloBios Pharma (KBIO) Announces Filing of 10-Q, 10-K for 2015 Sep 2, 2016 07:31AM
KaloBios Files Outstanding 10-Q and 10-K for 2015 Sep 2, 2016 07:30AM


Aug 29, 2016 09:28AM KaloBios Pharma (KBIOQ) Affirms Martin Shkreli Exit of Stake in Company
Aug 29, 2016 09:25AM KaloBios Announces Martin Shkreli’s Sale of His Stake in the Company
Jan 12, 2016 04:17PM KaloBios Pharma (KBIO) Withdraws Nasdaq Listing Appeal
Jan 12, 2016 04:15PM KaloBios Pharmaceuticals, Inc. Withdraws Appeal on Nasdaq Delisting
Jan 11, 2016 11:48AM KaloBios Pharma (KBIO) Says Michael Harrison Resigned From Board; Two New Board Members Named
Jan 11, 2016 11:46AM KaloBios Pharmaceuticals, Inc. Announces Board Changes and New Appointments
Dec 31, 2015 10:59AM NASDAQ Sees Additional Basis for Delisting KaloBios Pharma (KBIO)
Dec 31, 2015 10:57AM KaloBios Pharmaceuticals, Inc. Notified by Nasdaq Stock Market of Additional Bases for Delisting
Dec 30, 2015 05:28PM Market Wrap: Commodities Weigh on Market; GE to Split Out Renewables Unit; KaloBios Goes Bankrupt
Dec 30, 2015 11:21AM KaloBios Pharma (KBIO) Affirms Filing for Chapter 11 Bankruptcy
Dec 30, 2015 11:20AM KaloBios Pharmaceuticals, Inc. Files For Chapter 11 Bankruptcy Protection
Dec 30, 2015 06:16AM KaloBios Pharma (KBIO) Files for Bankruptcy
Nov 5, 2015 05:30PM KaloBios to Reduce Workforce, Explore Strategic Alternatives